Source:http://linkedlifedata.com/resource/pubmed/id/10970951
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2000-10-10
|
pubmed:abstractText |
Prolactinoma usually occurs a small intrasellar tumor in women or as a large tumor in men. To determine whether the predominance of macroprolactinomas in men is due to a delay in diagnosis as has been suggested, or whether there is a sex-related difference in growth rate we conducted a retrospective study in 45 men and 51 women with prolactinomas. Preoperative prolactin level (PRL) was 2,789 573 ng/ml and mean tumor size was 26 2 mm. Prolactin levels and tumor size were significantly higher in women (292 74 ng/ml and 10 1 mm; p<0.01). There was no correlation with age at diagnosis or duration of symptoms. Giant tumors were only observed in men (n=8). Frequency of resistance to bromocriptine (30% vs 5%, p<0.01) and invasive tumors (52% vs 27%, p<0.001) were significantly higher in men than in women. Likewise, proliferation rate was higher for the prolactinomas in men (Ki-67: 2.6 1.1% positive nuclei vs 0.4 0.2%; p=0.08; PCNA: 5.0 2.3% vs 3.7 1.1%). In conclusion, prolactinomas in men are more aggressive than in women. They grow rapidly, often invade the cavernous sinus and are resistant to bromocriptine; proliferation rates can be increased.
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Bromocriptine,
http://linkedlifedata.com/resource/pubmed/chemical/Hormone Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Ki-67 Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Prolactin,
http://linkedlifedata.com/resource/pubmed/chemical/Proliferating Cell Nuclear Antigen
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0003-4266
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
61
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
253-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10970951-Adolescent,
pubmed-meshheading:10970951-Adult,
pubmed-meshheading:10970951-Bromocriptine,
pubmed-meshheading:10970951-Cell Division,
pubmed-meshheading:10970951-Drug Resistance,
pubmed-meshheading:10970951-Female,
pubmed-meshheading:10970951-Hormone Antagonists,
pubmed-meshheading:10970951-Humans,
pubmed-meshheading:10970951-Ki-67 Antigen,
pubmed-meshheading:10970951-Male,
pubmed-meshheading:10970951-Neoplasm Invasiveness,
pubmed-meshheading:10970951-Pituitary Neoplasms,
pubmed-meshheading:10970951-Prolactin,
pubmed-meshheading:10970951-Prolactinoma,
pubmed-meshheading:10970951-Proliferating Cell Nuclear Antigen,
pubmed-meshheading:10970951-Retrospective Studies,
pubmed-meshheading:10970951-Sex Characteristics
|
pubmed:year |
2000
|
pubmed:articleTitle |
[Prolactinoma in man: clinical and histological characteristics].
|
pubmed:affiliation |
Laboratoire d'Histologie et Embryologie moléculaires, unité INSERM U433, Faculté de médecine Lyon-RTH Laennec, 69372 Lyon cedex 08, France.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract
|